RPL12P24

Across TCGA pan-cancer cohorts, RPL12P24 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPL12P24 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RPL12P24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL12P24 expression acts as an unfavorable survival marker.

BRCA, READ, and STAD are the cancer types where RPL12P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.570	1.000	.033	54	view →
READ	DFS	Tertile	IV	0.272	0.661	.004	45	view →
STAD	OS	Quartile	II,III,IV	0.365	0.641	.004	44	view →
ESCA	OS	Tertile	IV	0.135	0.568	.031	36	view →
COAD	OS	Tertile	IV	0.056	0.659	<.001	18	view →
BLCA	DFS	Tertile	IV	0.285	0.496	.030	12	view →
GBM	DFS	Tertile	All	0.188	0.268	.015	9	view →
PCPG	DFS	Tertile	All	0.086	0.846	.001	9	view →
LGG	DFS	Tertile	All	0.218	0.464	.029	3	view →
LIHC	OS	Tertile	All	0.332	0.593	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RPL12P24–BRCA (DFS)

Open the BRCA breakdown →